Keywords: enrollment, complete, ph, ii/iii, duocort, trial, helsingborg

Enrollment complete in Ph II/III DuoCort trial

Article | 17 December 2007

Print This

Helsingborg, Sweden-based DuoCort Pharma AB says that targeted enrollment is complete in a pivotal Phase II/III trial evaluating 5mg ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in